Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-25

FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) from Kenvue Brands LLC, indicating a label/indication update for treatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC HIVES (cetirizine hydrochloride)

Snippet

SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)